TopoTarget

#	Item
1	Mesothelioma Articles - CuraGen and TopoTarget Announce Initi... Add to Reading List Source URL: www.mirg.org Language: English - Date: 2010-10-19 13:01:04 Cancer research TopoTarget Mood stabilizers Mesothelioma Histone deacetylase inhibitor Belinostat Paclitaxel Histone deacetylase Medicine Chemistry Oncology
2	Gloucester Pharmaceuticals Acquires Worldwide Development and Commercialization Rights to Novel Anti-Cancer Compound from Fujisawa -Novel HDAC Inhibitor is in Phase II clinical studies for hematologic and solid tumor ind Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-12-10 01:08:01 Orphan drugs Histone deacetylase inhibitor Romidepsin Depsipeptide Histone deacetylase Cutaneous T-cell lymphoma Astellas Pharma TopoTarget Medicine Pharmacology Mood stabilizers
3	Corporate Introduction (NASDAQ: ENMD) January[removed] Add to Reading List Source URL: www.entremed.com Language: English - Date: 2014-02-11 11:41:01 Drug discovery Pharmaceutical industry Clinical research Lexicon Pharmaceuticals TopoTarget Pharmacology Pharmaceutical sciences Drug development
4	Outlook 10 September 2010 Add to Reading List Source URL: www.proinvestor.com Language: English - Date: 2010-09-16 12:31:32 Orphan drugs Cancer research TopoTarget Belinostat Mood stabilizers Vorinostat Extravasation Bevacizumab Histone deacetylase inhibitor Chemistry Medicine Hydroxamic acids